ArticleArthritis & rheumatology (Hoboken, N.J.)2017

The Biomarkers of Lupus Disease Study: A Bold Approach May Mitigate Interference of Background Immunosuppressants in Clinical Trials.

Joan T Merrill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.